Literature DB >> 1692828

Structural characterization of natural and recombinant human granulocyte colony-stimulating factors.

N Kubota1, T Orita, K Hattori, M Oh-eda, N Ochi, T Yamazaki.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein which stimulates predominantly neutrophilic granulocyte colony formation in mammals. Natural human G-CSF (hG-CSF) and recombinant hG-CSF produced in Chinese hamster ovary (CHO) cells transfected with the cDNA clone for hG-CSF have been purified to apparent homogeneity for structural and biological comparison. The amino acid sequence of recombinant hG-CSF, composed of 174 amino acid residues, was identical with that of natural hG-CSF and also with the sequence predicted from the cDNA. Both forms of hG-CSF have a free Cys-17 and two intramolecular disulfide linkages, between Cys-36 and Cys-42, and between Cys-64 and Cys-74. The O-glycosylation occurred at Thr-133 in both hG-CSFs. Similar CD spectra were obtained for both hG-CSFs. Additionally, both forms showed almost the same biological activities determined by in vitro colony-forming assay and in vivo assay. It is thus concluded that the recombinant hG-CSF is indistinguishable from its natural counterpart and that the former is valuable for more detailed characterization and clinical use.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692828     DOI: 10.1093/oxfordjournals.jbchem.a123072

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  29 in total

1.  Basic pharmacodynamic models for agents that alter production of natural cells.

Authors:  W Krzyzanski; R Ramakrishnan; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-10

Review 2.  G-CSF: status quo and new indications.

Authors:  F Herrmann
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

3.  Amino acid distributions around O-linked glycosylation sites.

Authors:  I B Wilson; Y Gavel; G von Heijne
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

4.  A 3,387 bp 5'-flanking sequence of the goat alpha-S1-casein gene provides correct tissue-specific expression of human granulocyte colony-stimulating factor (hG-CSF) in the mammary gland of transgenic mice.

Authors:  Irina A Serova; Gennady A Dvoryanchikov; Ludmila E Andreeva; Ivan A Burkov; Luciene P B Dias; Nariman R Battulin; Alexander V Smirnov; Oleg L Serov
Journal:  Transgenic Res       Date:  2011-09-01       Impact factor: 2.788

5.  The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors.

Authors:  C P Hill; T D Osslund; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

6.  Site-Specific Protein PEGylation: Application to Cysteine Analogs of Recombinant Human Granulocyte Colony-Stimulating Factor.

Authors:  Mary S Rosendahl; Daniel H Doherty; Darin J Smith; Alison M Bendele; George N Cox
Journal:  Bioprocess Int       Date:  2005-04

Review 7.  Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

8.  Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia.

Authors:  D Faulds; N J Lewis; R J Milne
Journal:  Pharmacoeconomics       Date:  1992-04       Impact factor: 4.981

Review 9.  Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.

Authors:  J E Frampton; Y E Yarker; K L Goa
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.